Partial prevention of glucocorticoid-induced osteocyte deterioration in young male mice with osteocrin gene therapy.

Mazur, Courtney M; Castro Andrade, Christian D; Tokavanich, Nicha; Sato, Tadatoshi; Bruce, Michael; Brooks, Daniel J; Bouxsein, Mary L; Wang, Jialiang S; Wein, Marc N

Mazur, Courtney M; Castro Andrade, Christian D; Tokavanich, Nicha; Sato, Tadatoshi; Bruce, Michael; Brooks, Daniel J; Bouxsein, Mary L; Wang, Jialiang S; Wein, Marc N.

Afiliação

Mazur CM; Endocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Castro Andrade CD; Endocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Tokavanich N; Endocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Sato T; Endocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Bruce M; Endocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Brooks DJ; Endocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Bouxsein ML; Center for Advanced Orthopedic Studies, Department of Orthopedic Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Wang JS; Endocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Wein MN; Center for Advanced Orthopedic Studies, Department of Orthopedic Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

iScience ; 25(9): 105019, 2022 Sep 16.

Article em En | MEDLINE | ID: mdl-36105586

Palavras-chave

Orthopedics; endocrinology; molecular biology

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google